Search Results
81 items found for "China M Payne"
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
SMOOTHENED-PKA signaling in the Hedgehog cascade Elita Yuliantie , Arthur Christopoulos , Patrick M.
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
M., & Lefkowitz, R. J. (2003).
- 📰 GPCR Weekly News, May 8 to 14, 2023
Continuing Study Addex Therapeutics in the 23rd BioEquity Europe Conference Simon Bekker-Jensen and Mette M
- 📰 GPCR Weekly News, March 11 to 17, 2024
This week's highlight includes congrats to: Makaía M Papasergi-Scott, Peter Gmeiner, Brian K Kobilka,
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Devki D Sukhtankar and Pina M Cardarelli's research: Burixafor Hydrobromide (GPC-100) effects on hematopoietic
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
Anson, M., et al., Incidence of new onset type 2 diabetes in adults living with obesity treated with
- 📰 GPCR Weekly News, February 5 to 11, 2024
Magdalena M Scharf, Antonella Di Pizio, Ines Liebscher, Hannes Schihada, and Gunnar Schulte et al. on
- 📰 GPCR Weekly News, January 8 to 14, 2024
Kathleen M Caron and her team studied the GPER/GPR30 complex with β1-adrenergic receptor and AKAP5 in
- 📰 GPCR Weekly News, May 27 to June 2, 2024
Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290 Crinetics Pharmaceuticals Appoints Robert M.
- 📰 GPCR Weekly News, February 12 to 18, 2024
Nayara Braga Emidio, Ross Cheloha, Laura M Wingler, et al. for their work on Nanobody-Mediated Dualsteric
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
Maziarz, M., et al., Revealing the Activity of Trimeric G-proteins in Live Cells with a Versatile Biosensor
- 📰 GPCR Weekly News, April 8 to 14, 2024
insights into G protein coupling specificity at a class A GPCR Jianjun Cao, Arthur Christopoulos, Patrick M.
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
Burger , Arthur Christopoulos , David M.
- Odorant receptors – a bit of smell for drug discovery
genito-urinary system, the activation of ORs was shown to influence the motility of spermatozoa (Spehr M.
- Overview of adhesion GPCRs self-activation
highlighted a new hydrophobic conserved motif composed of phenylalanine (F)/leucine (L) and methionine (M)
- Opioid Receptors and Protonation-Coupled Binding of Opioid Drugs
receptors are G-protein-coupled receptors (GPCRs) part of cell signaling paths of direct interest to treat pain Pain may associate with inflamed tissue characterized by acidic pH. The potentially low pH at tissue targeted by opioid drugs in pain management could impact drug binding
- Exploring pharmacological inhibition of G q/11 as an analgesic strategy
has pro-nociceptive properties, suggesting that blockade of Gq/11 signalling could be beneficial for pain Experimental approach: We used a series of behavioural assays to evaluate the acute responses of mice to painful
- Regulators of G-protein signaling: essential players in GPCR signaling
Dysregulation of RGS proteins has been implicated in a range of diseases, including cardiovascular disease, pain Relating to pain, RGS4 in pain regulation is a topic of increasing interest because it has been identified G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Avrampou, K., et al., RGS4 Maintains Chronic Pain Symptoms in Rodent Models.
- Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated
Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated Antinociception "Pain The current frontline approach for pain-management is the use of opioid analgesics.
- New role of β-arrestins in MOR signaling
Opioids are analgesic drugs consumed non-medically for euphoric feelings and medically for pain relief most important in regulating the response to nociception, i.e. the response of the nervous system to painful Given their pathophysiological significance in pain, addiction and depression opioid receptors represent Morphine is one of the most widely used and proven analgesic for the treatment of severe acute or chronic pain Complex Persistent Opioid Dependence-an Opioid-induced Chronic Pain Syndrome.
- Ode to GPCRs
Shampo, M. A. & Kyle, R. A. Sir Bernard Katz--winner of Nobel Prize in physiology or medicine. Ekaterini Tiligada, C., Tiligada, E. & Ennis, M.
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
of the proton-sensing GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain of the proton-sensing GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain
- Fentanyl activates ovarian cancer and alleviates chemotherapy-induced toxicity via opioid...
EGFR "Background Fentanyl is an opioid analgesic and is widely used in ovarian cancer patients for pain
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
preclinical data supports the applicability of CB2 activation in autoimmune and inflammatory diseases, pain
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future
preclinical data support the applicability of CB2 activation in autoimmune and inflammatory diseases, pain
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
rights to develop certain retained compounds for Charcot-Marie-Tooth type 1A neuropathy (CMT1A) and pain
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
drawback of causing damage to healthy cells in the process, leading to side effects that can include pain
- To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...
molecular dynamic simulations "The δ-opioid receptor (DOR) is a critical pharmaceutical target for pain